Quantum-Si to Present at The Festival of Genomics & Biodata 2023 in Boston, Massachusetts

0
89

BRANFORD, Conn.– Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), The Protein Sequencing Company™, today announced the Company and Senior Vice President of Product Development John Vieceli will be presenting at the 2023 Festival of Genomics & Biodata, and first-ever proteomics focused track. Additionally, Quantum-Si will also be presenting a poster throughout the duration of the conference. The Festival of Genomics & Biodata will take place October 4-5, 2023 at the Convention Center in Boston, Massachusetts.

“This year’s Festival of Genomics in Boston includes an eye toward the future of biological research and innovation. After several decades of vital DNA research and insights, we are now moving to the next frontier of important biological research: the human proteome,” said John Vieceli, Senior Vice President of Product Development at Quantum-Si. “At Quantum-Si we believe protein sequencing through instruments like Platinum ™ is the next important step for deciphering and understanding human biology, and we are pleased to see that a historically genomics- focused conference shares our passion to showcase critical advancements in proteomics research on their stage this year.”

Details of Quantum-Si’s Festival of Genomics & Biodata Participation:

October 4, 2023, 12:10 PM ET: Boston Convention Center, “Park Stage”
30 Minute Speaking Session
Speaker: John Vieceli, SVP of Product Development
Topic: Beyond the Genome: Using a Scalable Next-Generation Protein Sequencing Technology to Analyze the Proteome with Single Molecule Resolution and Increased Amino Acid Coverage

Boston Convention Center, Exhibit Hall
Poster Presentation:
Presenter: Kendrick Nguyen
Topic: Beyond the Genome: How Quantum-Si’s Platinum Identifies Protein Sequence and Post-Translational Modifications Often Overlooked by Genomics Data

Platinum, the world’s first next-generation single-molecule protein sequencing platform, uses proprietary recognizers to identify amino acids of proteins using kinetic binding signatures. Its elegant design and simple workflow enable broad-scale access to proteomic data, for every scientist, everywhere, making it a groundbreaking platform for the future of proteomics research. With its compact benchtop design and low price-point, Platinum is poised to accelerate breakthroughs across scientific disciplines, from drug discovery to biotech, and help people live healthier and longer lives.